Wendel Domestic bonds 1% 1jun2031 News - MFAN

Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), OrthoPediatrics (KIDS) and BioNano Genomics (BNGO)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Esperion (ESPR – Research Report), OrthoPediatrics...

Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN) and OrthoPediatrics (KIDS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aileron Therapeutics (ALRN – Research Report) and...

Stifel Nicolaus Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

In a report released on August 5, Rick Wise from Stifel Nicolaus maintained a Buy rating on OrthoPediatrics (KIDS - Research Report), with a price...

OrthoPediatrics (KIDS) Gets a Buy Rating from BTIG

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price target of...

OrthoPediatrics (KIDS) Received its Third Buy in a Row

After BTIG and Stifel Nicolaus gave OrthoPediatrics (NASDAQ: KIDS) a Buy rating last month, the company received another Buy, this time from...

OrthoPediatrics (KIDS) Gets a Buy Rating from BTIG

BTIG analyst Ryan Zimmerman maintained a Buy rating on OrthoPediatrics (KIDS – Research Report) today and set a price target of $65.00. The...

JMP Securities Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

JMP Securities analyst David Turkaly reiterated a Buy rating on OrthoPediatrics (KIDS – Research Report) today and set a price target of $77.00...

Analysts Conflicted on These Healthcare Names: Clovis Oncology (CLVS) and OrthoPediatrics (KIDS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Clovis Oncology (CLVS – Research Report) and...

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and OrthoPediatrics (KIDS)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Altimmune (ALT – Research Report) and...

Stifel Nicolaus Thinks OrthoPediatrics’ Stock is Going to Recover

In a report issued on May 6, Rick Wise from Stifel Nicolaus maintained a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price...

Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Concert Pharma (CNCE) and OrthoPediatrics (KIDS)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioCryst (BCRX – Research Report), Concert Pharma...

Needham Thinks OrthoPediatrics’ Stock is Going to Recover

Needham analyst Michael Matson reiterated a Buy rating on OrthoPediatrics (KIDS – Research Report) today and set a price target of $59.00. The...

JMP Securities Thinks OrthoPediatrics’ Stock is Going to Recover

In a report released today, David Turkaly from JMP Securities reiterated a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price...

Needham Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

In a report released today, Michael Matson from Needham maintained a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price target...

OrthoPediatrics (KIDS) Received its Third Buy in a Row

After Stifel Nicolaus and BTIG gave OrthoPediatrics (NASDAQ: KIDS) a Buy rating last month, the company received another Buy, this time from JMP...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Wendel Domestic bonds 1% 1jun2031 (MFAN)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

MFAN News

Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), OrthoPediatrics (KIDS) and BioNano Genomics (BNGO)

Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN) and OrthoPediatrics (KIDS)

Stifel Nicolaus Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

OrthoPediatrics (KIDS) Gets a Buy Rating from BTIG

OrthoPediatrics (KIDS) Received its Third Buy in a Row

OrthoPediatrics (KIDS) Gets a Buy Rating from BTIG

JMP Securities Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

Analysts Conflicted on These Healthcare Names: Clovis Oncology (CLVS) and OrthoPediatrics (KIDS)

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and OrthoPediatrics (KIDS)

Stifel Nicolaus Thinks OrthoPediatrics’ Stock is Going to Recover

Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Concert Pharma (CNCE) and OrthoPediatrics (KIDS)

Needham Thinks OrthoPediatrics’ Stock is Going to Recover

JMP Securities Thinks OrthoPediatrics’ Stock is Going to Recover

Needham Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

OrthoPediatrics (KIDS) Received its Third Buy in a Row

MFAN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Wendel Domestic bonds 1% 1jun2031 (MFAN) News

Wendel Domestic bonds 1% 1jun2031 (MFAN)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

MFAN News

Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), OrthoPediatrics (KIDS) and BioNano Genomics (BNGO)

Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN) and OrthoPediatrics (KIDS)

Stifel Nicolaus Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

OrthoPediatrics (KIDS) Gets a Buy Rating from BTIG

OrthoPediatrics (KIDS) Received its Third Buy in a Row

OrthoPediatrics (KIDS) Gets a Buy Rating from BTIG

JMP Securities Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

Analysts Conflicted on These Healthcare Names: Clovis Oncology (CLVS) and OrthoPediatrics (KIDS)

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and OrthoPediatrics (KIDS)

Stifel Nicolaus Thinks OrthoPediatrics’ Stock is Going to Recover

Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Concert Pharma (CNCE) and OrthoPediatrics (KIDS)

Needham Thinks OrthoPediatrics’ Stock is Going to Recover

JMP Securities Thinks OrthoPediatrics’ Stock is Going to Recover

Needham Sticks to Their Buy Rating for OrthoPediatrics (KIDS)

OrthoPediatrics (KIDS) Received its Third Buy in a Row

MFAN Discussion

Your Recent History